Hunan Huize Biopharmaceutical Technology

Hunan Huize Biopharmaceutical Technology is a prominent Chinese Contract Research Organization (CRO) that provides comprehensive clinical research services to the pharmaceutical industry. Established in 2014 and based in Changsha, the company specializes in Phase I-IV clinical trials, bioequivalence (BE) studies, and sophisticated bioanalytical testing. Hunan Huize operates state-of-the-art clinical research centers and laboratories focused on pharmacokinetics, pharmacodynamics, and drug metabolism. The organization is known for its deep expertise in NMPA regulatory standards, assisting clients in accelerating the development of both innovative new drugs and high-quality generics. Their service portfolio also includes data management, statistical analysis, and medical writing. By leveraging strong academic ties and modern technology platforms, the company helps domestic and international pharmaceutical firms accelerate their time-to-market.